Literature DB >> 23122777

Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity.

V Cassina1, A Torsello, A Tempestini, D Salerno, D Brogioli, L Tamiazzo, E Bresciani, J Martinez, J A Fehrentz, P Verdié, R J Omeljaniuk, R Possenti, L Rizzi, V Locatelli, F Mantegazza.   

Abstract

Recently, we demonstrated that TLQP-21 triggers lipolysis and induces resistance to obesity by reducing fat accumulation [1]. TLQP-21 is a 21 amino acid peptide cleavage product of the neuroprotein VGF and was first identified in rat brain. Although TLQP-21 biological activity and its molecular signaling is under active investigation, a receptor for TLQP-21 has not yet been characterized. We now demonstrate that TLQP-21 stimulates intracellular calcium mobilization in CHO cells. Furthermore, using Atomic Force Microscopy (AFM), we also provide evidence of TLQP-21 binding-site characteristics in CHO cells. AFM was used in force mapping mode equipped with a cantilever suitably functionalized with TLQP-21. Attraction of this functionalized probe to the cell surface was specific and consistent with the biological activity of TLQP-21; by contrast, there was no attraction of a probe functionalized with biologically inactive analogues. We detected interaction of the peptide with the binding-site by scanning the cell surface with the cantilever tip. The attractive force between TLQP-21 and its binding site was measured, statistically analyzed and quantified at approximately 40 pN on average, indicating a single class of binding sites. Furthermore we observed that the distribution of these binding sites on the surface was relatively uniform.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122777     DOI: 10.1016/j.bbamem.2012.10.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.

Authors:  Sebastien Hannedouche; Valerie Beck; Juliet Leighton-Davies; Martin Beibel; Guglielmo Roma; Edward J Oakeley; Vincent Lannoy; Jerome Bernard; Jacques Hamon; Samuel Barbieri; Inga Preuss; Marie-Christine Lasbennes; Andreas W Sailer; Thomas Suply; Klaus Seuwen; Christian N Parker; Frederic Bassilana
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

2.  Clearance kinetics of the VGF-derived neuropeptide TLQP-21.

Authors:  ZengKui Guo; Bhavani S Sahu; Rongjun He; Brian Finan; Cheryl Cero; Raffaello Verardi; Maria Razzoli; Gianluigi Veglia; Richard D Di Marchi; John M Miles; Alessandro Bartolomucci
Journal:  Neuropeptides       Date:  2018-06-19       Impact factor: 3.286

3.  JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.

Authors:  Elena Bresciani; Laura Rizzi; Laura Molteni; Monica Ravelli; Antonella Liantonio; Khoubaib Ben Haj Salah; Jean-Alain Fehrentz; Jean Martinez; Robert J Omeljaniuk; Giuseppe Biagini; Vittorio Locatelli; Antonio Torsello
Journal:  Endocrine       Date:  2016-11-28       Impact factor: 3.633

4.  The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.

Authors:  Cheryl Cero; Vitaly V Vostrikov; Raffaello Verardi; Cinzia Severini; Tata Gopinath; Patrick D Braun; Maria F Sassano; Allison Gurney; Bryan L Roth; Lucy Vulchanova; Roberta Possenti; Gianluigi Veglia; Alessandro Bartolomucci
Journal:  Structure       Date:  2014-11-13       Impact factor: 5.006

Review 5.  Modulation of pancreatic exocrine and endocrine secretion.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

Review 6.  Neuroendocrine Role for VGF.

Authors:  Jo E Lewis; John M Brameld; Preeti H Jethwa
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-02       Impact factor: 5.555

7.  Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.

Authors:  Laura Molteni; Laura Rizzi; Elena Bresciani; Roberta Possenti; Pamela Petrocchi Passeri; Corrado Ghè; Giampiero Muccioli; Jean-Alain Fehrentz; Pascal Verdié; Jean Martinez; Robert J Omeljaniuk; Giuseppe Biagini; Anna Binda; Ilaria Rivolta; Vittorio Locatelli; Antonio Torsello
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

8.  JMV5656, A Novel Derivative of TLQP-21, Triggers the Activation of a Calcium-Dependent Potassium Outward Current in Microglial Cells.

Authors:  Ilaria Rivolta; Anna Binda; Laura Molteni; Laura Rizzi; Elena Bresciani; Roberta Possenti; Jean-Alain Fehrentz; Pascal Verdié; Jean Martinez; Robert J Omeljaniuk; Vittorio Locatelli; Antonio Torsello
Journal:  Front Cell Neurosci       Date:  2017-02-23       Impact factor: 5.505

9.  STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages.

Authors:  Laura Molteni; Laura Rizzi; Elena Bresciani; Ramona Meanti; Jean-Alain Fehrentz; Pascal Verdié; Robert J Omeljaniuk; Giuseppe Biagini; Vittorio Locatelli; Antonio Torsello
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

10.  Identification of a receptor for neuropeptide VGF and its role in neuropathic pain.

Authors:  Ya-Chun Chen; Alessandro Pristerá; Mahmood Ayub; Richard S Swanwick; Kersti Karu; Yosuke Hamada; Andrew S C Rice; Kenji Okuse
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.